Novira Therapeutics Gets Seeded

Novira Therapeutics Inc., a Philadelphia-based developer of antiviral therapeutics, has raised $550,000 in seed funding from BioAdvance.

30 March 2009•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.